Welcome to the 
Delaware Society for Clinical Oncology

The Current and Future Role of PARP Inhibition in the Management of Ovarian Cancer

  • 11 Apr 2019
  • 6:00 PM - 8:00 PM
  • Medical Society of Delaware (900 Prides Crossing, Newark, DE 19713)

Registration

This educational activity is provided by Research to Practice and will be presented by Michael Birrer, MD, PhD, Director, O'Neal Comprehensive Cancer Center, Professor of Medicine/Hematology and Oncology, Evalina Spencer Chair in Oncology, The University of Alabama at Birmingham, Birmingham, Alabama.  

 

THIS EVENT IS NOT OPEN TO THE PUBLIC.


Delaware Society for Clinical Oncology
c/o Megan Hayes
Medical Society of Delaware
900 Prides Crossing, Newark, Delaware 19713
Tel: 302-224-5181, Fax: 302-366-1354, Email: Megan.Hayes@medsocdel.org

This website brought to you by:

 

Terms and Conditions of Use

 Website design by Sister Webs Design Studio, where 5% of profits are donated to women's cancer funds

Powered by Wild Apricot Membership Software